Hear from a panel of experts discussing bridging the gaps in precision oncology: opportunities in non-small cell lung cancer
Host Fred Goldstein invites Ruby Singh, Senior Vice President of Education and Instruction and Brittany Henry, Director of Education Programs, with AMCP, to discuss the brand-new 3rd edition of the AMCP Fundamentals of Managed Care Pharmacy Training Program scheduled for release July 2023.
Chronic lymphocytic leukemia (CLL) is a chronic
lymphoproliferative disorder (lymphoid neoplasm).
It is characterized by a progressive accumulation of
functionally incompetent B lymphocytes, which are
usually monoclonal in origin.
The lack of implementation of predictive biomarkers in clinical practice results in a significant number of individuals with NSCLC not deriving benefits from targeted treatments. Payers have the potential to shape various aspects of the precision oncology pathway, such as addressing biomarker test ordering, utilizing test results to inform treatment decisions, implementing quality measurements, and understanding cost-effectiveness.
Hear from a panel of experts discussing implementing continuous glucose monitoring interventions to improve outcomes for members with diabetes.
Hear from a panel of experts discussing biomarker testing in non-small cell lung cancer
The lack of implementation of predictive biomarkers in clinical practice results in a significant number of individuals with NSCLC not deriving benefits from targeted treatments. Payers have the potential to shape various aspects of the precision oncology pathway, such as addressing biomarker test ordering, utilizing test results to inform treatment decisions, implementing quality measurements, and understanding cost-effectiveness.
Hear from a panel of experts discussing exploring opportunities to improve quality of life for those with Amyotrophic Lateral Sclerosis (ALS).
On June 2, 2023, CMS issued a memo via HPMS reminding plan sponsors of requirements
related to the pharmacy price concessions provisions in the May 9, 2022 final rule (CMS-4192-
F).
Don't miss out on your chance to comment! Health care expert Fred Goldstein sits down with Ellen Whipple, BS Pharm, PharmD, to discuss the AMCP Format revision focused on digital therapeutics, health disparities, real-world evidence, PIE Deck guidance, and streamlining dossier development.
